Related Experiment Video
Updated: Jun 20, 2026
04:44
Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Castleman's disease: an intrapulmonary form with intrafissural development.
Hajer Racil1, Sana Cheikh Rouhou, Olfa Ismail
1Pulmonology Department, Pavillon II, Abderrahman Mami Hospital, Ariana,Tunisia.
Thescientificworldjournal
|September 22, 2009
Summary
Castleman's disease (CD) is a rare lymphoproliferative disorder. This report details an unusual intrapulmonary CD case with atypical imaging findings, highlighting its rarity and surgical management.
Area of Science:
- Pulmonology
- Oncology
- Pathology
Background:
- Castleman's disease (CD) is a rare lymphoproliferative disorder of unknown cause.
- It predominantly affects the mediastinum, with pulmonary involvement being exceptionally uncommon.
- Typical imaging findings often include good contrast enhancement.
Purpose of the Study:
- To report a unique case of Castleman's disease presenting with intrapulmonary and intrafissural involvement.
- To highlight atypical imaging characteristics, specifically poor contrast enhancement.
- To discuss the diagnostic and surgical challenges of intrapulmonary Castleman's disease.
Main Methods:
- Case report of a 23-year-old female with a 4-year history of respiratory symptoms.
- Diagnostic workup included chest X-ray and computed tomography (CT) scans.
- Surgical resection of the mass followed by histopathological examination.
Main Results:
- CT revealed a right lower lobe mass with poor contrast enhancement and associated lymphadenopathy.
- Surgical exploration identified a right hilar compressive mass with intrafissural development.
- Pneumonectomy was necessary due to significant intraoperative bleeding.
Conclusions:
- Intrapulmonary Castleman's disease is rare, and intrafissural development is an unusual presentation.
- Poor contrast enhancement on CT can be an atypical feature of Castleman's disease.
- Surgical intervention is crucial for diagnosis and treatment, though complications like bleeding can occur.
Related Concept Videos
01:28Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:31Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:19Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...